Related Experiment Video

Updated: Jul 16, 2026

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis
10:22

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Published on: August 15, 2013

Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of

Patrick T Gunning1, William P Katt, Matthew Glenn

  • 1Department of Chemistry, Yale University, New Haven, CT, USA.

Bioorganic & Medicinal Chemistry Letters
|March 6, 2007
PubMed

Insights

Researchers developed peptidomimetic inhibitors to disrupt Signal Transducers and Activators of Transcription (STAT) protein dimerization in cancer. One agent, ISS840, selectively inhibits STAT1 dimerization over STAT3, offering a potential therapeutic strategy for STAT-driven cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Drug Discovery

Background:

  • Constitutively activated Signal Transducers and Activators of Transcription (STAT) proteins are implicated in aberrant cell signaling pathways driving oncogenesis.
  • Targeting specific STAT isoforms involved in cancer provides a potential therapeutic strategy.

Purpose of the Study:

  • To identify agents that selectively disrupt STAT protein homo-dimerization.
  • To investigate peptidomimetic inhibitors targeting STAT1 and STAT3 isoforms associated with cancer.

Main Methods:

  • Design and synthesis of a library of peptidomimetic inhibitors.
  • Assay development to measure STAT1 and STAT3 homo-dimerization inhibition.
  • Determination of IC50 values for selective inhibition.

Main Results:

  • Identified peptidomimetic agents capable of selectively disrupting STAT1 or STAT3 homo-dimerization at low micromolar concentrations.
  • The inhibitor ISS840 demonstrated a 20-fold higher inhibition of STAT1 homo-dimerization (IC50 = 31 microM) compared to STAT3 (IC50 = 560 microM).

Conclusions:

  • Peptidomimetic inhibitors can be designed to selectively target STAT protein homo-dimerization.
  • ISS840 represents a promising lead compound for developing therapies against STAT1-dependent cancers.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay09:18

Detection of Heterodimerization of Protein Isoforms Using an in Situ Proximity Ligation Assay

Published on: October 20, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...